Division of Neurosurgery, Department of Surgery, 4/F Clinical Science Building, Prince of Wales Hospital, The Chinese University of Hong Kong, 1 Ngan Shing Street, Shatin, New Territories, Hong Kong.
J Clin Neurosci. 2012 Sep;19(9):1252-4. doi: 10.1016/j.jocn.2012.01.010. Epub 2012 Jul 10.
The modified radiosurgery-based arteriovenous malformation (AVM) score (modified AVM score or Pollock-Flickinger AVM score [PFAS]) is a simplified grading system developed to predict outcome after gamma knife radiosurgery for cerebral AVM. The purpose of this study was to test the PFAS in a cohort of patients managed with linear accelerator (LINAC) radiosurgery. We analyzed 70 consecutive patients with cerebral AVM treated with LINAC radiosurgery in Hong Kong. The scores were determined by the following equation: Modified AVM score=(0.1×volume [cm(3)])+(0.02×age [years])+(0.5×location). The location values are as follows: hemispheric/corpus callosum/cerebellar=0; basal ganglia/thalamus/brainstem=1. A total of 74% of patients presented with ruptured AVM before radiosurgery. The overall obliteration rate was 86%. Five (7%) patients developed new permanent neurological deficits from delayed bleeding or radiation-induced complications. Modified AVM score correlated with the percentage of patients with AVM obliteration without new neurological deficits (≤1, 96%; 1.01-1.50, 78%; 1.51-2.00, 90%; >2, 50%; Spearman's rho 0.354, p=0.003). In conclusion, the modified AVM score is a good predictor of patient outcome after LINAC radiosurgery in our cohort. The modified AVM score can be used to guide treatment selection for cerebral AVM and stratify patients for future comparative analyses.
改良伽玛刀动静脉畸形(AVM)评分(改良 AVM 评分或 Pollock-Flickinger AVM 评分[PFAS])是一种简化的分级系统,旨在预测伽玛刀治疗脑 AVM 后的结果。本研究的目的是在接受直线加速器(LINAC)放射外科治疗的患者队列中测试 PFAS。我们分析了香港 70 例接受 LINAC 放射外科治疗的脑 AVM 患者。评分通过以下公式确定:改良 AVM 评分=(0.1×体积[cm3])+(0.02×年龄[岁])+(0.5×位置)。位置值如下:半球/胼胝体/小脑=0;基底节/丘脑/脑干=1。74%的患者在放射外科治疗前有破裂的 AVM。总的闭塞率为 86%。5(7%)例患者因迟发性出血或放射性并发症导致新的永久性神经功能缺损。改良 AVM 评分与无新神经功能缺损的 AVM 闭塞率相关(≤1,96%;1.01-1.50,78%;1.51-2.00,90%;>2,50%;Spearman's rho 0.354,p=0.003)。总之,改良 AVM 评分是我们队列中 LINAC 放射外科治疗后患者结局的良好预测指标。改良 AVM 评分可用于指导脑 AVM 的治疗选择,并对患者进行分层以进行未来的比较分析。